Image-Guided Programming for Cochlear Implants
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to improve hearing outcomes for children with cochlear implants through a new programming method called Image-Guided Cochlear Implant Programming (IGCIP). The method customizes implant settings based on detailed ear images, potentially enhancing speech and language development. The trial includes two groups: one receives the new programming immediately, while the other experiences a delay. Children aged 4 to 12 with early-onset hearing loss and at least one cochlear implant may be suitable candidates for this trial. As an unphased trial, it offers a unique opportunity to contribute to innovative research that could enhance future cochlear implant programming.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this image-guided cochlear implant programming method is safe for children?
Research shows that cochlear implants, which assist individuals with hearing loss, are generally safe. The FDA has approved these devices for treating hearing loss. A new programming method, Image-Guided Cochlear Implant Programming (IGCIP), uses images of the implant to tailor adjustments for each person.
Regarding safety, studies have found that remotely programming cochlear implants, similar to IGCIP, is safe and effective. No major safety issues have been reported for these types of adjustments. This suggests that IGCIP should also be safe for patients, although specific safety data for IGCIP isn't detailed in the sources. Overall, the technology has a strong safety record in similar applications, making it a promising option.12345Why are researchers excited about this trial?
Researchers are excited about the image-guided programming for cochlear implants because it introduces a personalized approach to signal processing. Unlike standard cochlear implant programming, which often relies on generic settings, this method uses imaging to tailor the signal processing specifically to the individual's ear anatomy. This has the potential to enhance hearing outcomes by optimizing how sound is processed for each person. The trial explores both immediate and deferred interventions, allowing researchers to assess the benefits and timing of this tailored approach.
What evidence suggests that image-guided cochlear implant programming is effective for improving speech and language outcomes in children?
Research shows that Image-Guided Cochlear Implant Programming (IGCIP) can greatly improve hearing for people with cochlear implants. Studies have found that IGCIP leads to better hearing results, especially in adults. This trial will compare two approaches: Immediate IGCIP, where the signal processing intervention is applied right away, and Deferred IGCIP, where the intervention is delayed. Researchers use CT scans to create a detailed map of the implant, allowing for a more personalized way to stimulate the ear. Early evidence suggests that IGCIP might also boost speech and language skills in children by focusing on the connection between the implant and the ear's nerve pathways. This method could be more effective than traditional approaches that don't consider the exact position of the implant in the ear.678910
Who Is on the Research Team?
Rene Gifford, PhD
Principal Investigator
Vanderbilt University Medical Center
Stephen Camarata, PhD
Principal Investigator
Vanderbilt University Medical Center
Are You a Good Fit for This Trial?
This trial is for children aged 4-12 with cochlear implants, implanted before age 4 due to prelingual deafness. They must have moderate to profound sensorineural hearing loss in both ears (or the non-CI ear), no severe cognitive impairments or disorders like autism, and typical nonverbal cognitive abilities. Severe temporal bone abnormalities or postlingual onset of hearing loss are disqualifiers.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Baseline assessment of auditory function, speech recognition, PA, reading, speech, and language abilities for pediatric CI users
Treatment
Immediate or deferred Image-guided Cochlear Implant Programming (IGCIP) intervention
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Signal processing intervention of a biomedical device
Find a Clinic Near You
Who Is Running the Clinical Trial?
Vanderbilt University Medical Center
Lead Sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator